Skip to main content
OpenTrials

Clinical trial condition

Nervous System Malformations

Explore clinical trials studying Nervous System Malformations. Study availability and eligibility vary by location and protocol.

624 public trials 152 recruiting studies
Refine in advanced search Browse all conditions

Nervous System Malformations trial results

Recruiting

Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors

NCT06667141

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, +13 more
Locations
  • HonorHealth Research Institute Phoenix, Arizona, United States
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Denver Health One Denver, Colorado, United States
View all 15 locations
View Trial Details
Recruiting

Spastic Paraplegia - Centers of Excellence Research Network

NCT06553976

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Early Onset Hereditary Spastic Paraplegia, +18 more
Locations
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • University of Iowa Carver College of Medicine Iowa City, Iowa, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT04657068

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adnexal Diseases, +55 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic (Arizona) Scottsdale, Arizona, United States
  • University of Arkansas - Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 79 locations
View Trial Details
Recruiting

A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)

NCT07064122

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations
  • Research Site Miami, Florida, United States
  • Research Site Tampa, Florida, United States
  • Research Site Houston, Texas, United States
  • Research Site Heidelberg, Australia
View all 21 locations
View Trial Details

Related conditions